Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IPILIMUMAB Cause Alanine aminotransferase increased? 389 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 389 reports of Alanine aminotransferase increased have been filed in association with IPILIMUMAB (YERVOY). This represents 1.1% of all adverse event reports for IPILIMUMAB.

389
Reports of Alanine aminotransferase increased with IPILIMUMAB
1.1%
of all IPILIMUMAB reports
59
Deaths
290
Hospitalizations

How Dangerous Is Alanine aminotransferase increased From IPILIMUMAB?

Of the 389 reports, 59 (15.2%) resulted in death, 290 (74.6%) required hospitalization, and 51 (13.1%) were considered life-threatening.

Is Alanine aminotransferase increased Listed in the Official Label?

Yes, Alanine aminotransferase increased is listed as a known adverse reaction in the official FDA drug label for IPILIMUMAB.

What Other Side Effects Does IPILIMUMAB Cause?

Death (3,710) Malignant neoplasm progression (3,296) Diarrhoea (2,557) Off label use (2,097) Colitis (1,988) Pyrexia (1,796) Rash (1,556) Fatigue (1,447) Intentional product use issue (1,329) Nausea (1,169)

What Other Drugs Cause Alanine aminotransferase increased?

METHOTREXATE (2,440) RITUXIMAB (1,651) ADALIMUMAB (1,308) TOCILIZUMAB (1,163) ETANERCEPT (1,131) LEFLUNOMIDE (1,099) ACETAMINOPHEN (1,083) REMDESIVIR (1,047) FINGOLIMOD (1,020) INFLIXIMAB (981)

Which IPILIMUMAB Alternatives Have Lower Alanine aminotransferase increased Risk?

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE IPILIMUMAB vs IPRATROPIUM IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS IPILIMUMAB vs IPTACOPAN IPILIMUMAB vs IRBESARTAN

Related Pages

IPILIMUMAB Full Profile All Alanine aminotransferase increased Reports All Drugs Causing Alanine aminotransferase increased IPILIMUMAB Demographics